An essential tool for detection of respiratory illnesses

By performing just a single test healthcare personnel is now able to simultaneously detect eighteen of the most prevalent respiratory infections in patients. The Seeplex 18-plex Respiratory Test is a highly economical method for molecular diagnostics of respiratory infections. It achieves results rapidly at minimal costs per test.

Photo: An essential tool for detection of respiratory illnesses

Seegene invents its new Seeplex 18-plex Respiratory Test as an essential tool for active surveillance and treatment of respiratory illnesses. Compared to the usual ‘single pathogen – single test’ testing regime the new multiplex-formatted diagnostic test, for which nasopharyngeal spirates, nasopharyngeal swabs or bronchoalveolar lavage samples could be used, is cost-effective and delivers fast results.

The Test detects the following  RNA viruses, DNA viruses and pneumonia bacteria:

      -          Influenza A virus
-          Influenza B virus
-          Human respiratory syncytial virus A
-          Human respiratory syncytial cirus B
-          Human parainfluenzae virus 1
-          Human parainfluenzae virus 2
-          Human parainfluenzae virus 3
-          Human coronavirus 229E/NL63
-          Human coronavirus OC43/HKU1
-          Human rhinovirus
-          Human enterovirus
-          Human adenovirus
-          Human bocavirus
-          Legionella pneumoniae
-          Streptococcus pneumoniae
-          Chlamydophila pneumoniae
-          Haemophilus influenzae
-          Mycoplasma pneumoniae

14.09.2007

More on the subject:

Related articles

Photo

News • Human cytomegalovirus

How HMCV evades the immune system

Human cytomegalovirus (HCMV) is a major global health burden that causes lifelong infection in humans. Researchers have now shown how the virus escapes immune surveillance.

Photo

Sponsored • Produced in partnership with FUJIFILM Wako

Beta-D-glucan testing: More than a single result

Invasive fungal infections remain among the most challenging diagnoses in clinical microbiology. Beta-D-glucan (BDG) testing has emerged as a valuable non-invasive biomarker – but its true utility…

Photo

Interview • Resilience in healthcare

“We need redundancy at every level”

The threat of hybrid attacks in Germany is increasing. In this exclusive interview with MedLabPortal, DGKL CEO Jan Wolter highlights existing vulnerabilities and calls on policymakers to take action.

Subscribe to Newsletter